NDC Package Code : 71052-509
Start Marketing Date : 2020-01-07
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (5g/5g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
41
PharmaCompass offers a list of Miltefosine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Miltefosine manufacturer or Miltefosine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Miltefosine manufacturer or Miltefosine supplier.
PharmaCompass also assists you with knowing the Miltefosine API Price utilized in the formulation of products. Miltefosine API Price is not always fixed or binding as the Miltefosine Price is obtained through a variety of data sources. The Miltefosine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Miltefosine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Miltefosine, including repackagers and relabelers. The FDA regulates Miltefosine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Miltefosine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Miltefosine supplier is an individual or a company that provides Miltefosine active pharmaceutical ingredient (API) or Miltefosine finished formulations upon request. The Miltefosine suppliers may include Miltefosine API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Miltefosine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Miltefosine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Miltefosine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Miltefosine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Miltefosine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Miltefosine suppliers with NDC on PharmaCompass.
